Paper Details
- Home
- Paper Details
Pharmacokinetics of dolasetron after oral and intravenous administration of dolasetron mesylate in healthy volunteers and patients with hepatic dysfunction.
Author: DimmittD C, HahneW F, MartinL A, PreadyN, StubbsK
Original Abstract of the Article :
In previous studies, dolasetron was shown to have both renal and hepatic elimination mechanisms. This study was conducted to determine the impact of varying degrees of hepatic dysfunction on the pharmacokinetics and safety of dolasetron and its reduced metabolites. Seventeen adults were studied: six...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1002/j.1552-4604.1997.tb04267.x
データ提供:米国国立医学図書館(NLM)
Dolasetron's Pharmacokinetics: A Journey Through the Liver
Dolasetron, an antiemetic drug, is used to prevent nausea and vomiting associated with chemotherapy and surgery. This research investigates the pharmacokinetics of dolasetron in individuals with varying degrees of hepatic dysfunction. The study examined the impact of hepatic impairment on the pharmacokinetics of dolasetron and its metabolites after both oral and intravenous administration. The study found that hepatic impairment had a minimal impact on dolasetron's pharmacokinetics, suggesting that dose adjustments are not necessary for patients with hepatic disease and normal renal function.
Navigating the Desert of Liver Function
The study's findings provide reassurance for healthcare professionals prescribing dolasetron to patients with hepatic dysfunction. The research suggests that dolasetron can be used safely in this population without significant adjustments to the dosage. It's like navigating a desert, where a traveler can safely continue their journey with minimal adjustments to their route based on the terrain.
Understanding Drug Metabolism and Individual Differences
This study highlights the importance of understanding drug metabolism and individual differences in patient response. It emphasizes the need for careful monitoring and individualized treatment plans, particularly when treating patients with hepatic dysfunction. Just as a desert traveler needs to adapt their strategy based on the specific conditions of the terrain, healthcare providers need to consider individual patient factors when prescribing medications.
Dr. Camel's Conclusion
This study explores the pharmacokinetics of dolasetron in individuals with hepatic dysfunction. The findings provide valuable insights into the drug's behavior in patients with varying degrees of liver impairment. This research underscores the importance of considering individual patient factors when prescribing medications, reminding us that just as a desert traveler needs to adapt their approach to the specific challenges of the terrain, healthcare professionals need to tailor their treatment strategies based on individual patient needs.
Date :
- Date Completed 1998-03-30
- Date Revised 2019-08-26
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.